Scientists probe hidden link between diabetes, fatty liver, and glucagon resistance
NCT ID NCT07246421
First seen Jan 08, 2026 · Last updated May 15, 2026 · Updated 25 times
Summary
This study looks at how the hormone glucagon works in people with type 2 diabetes, especially those who also have fatty liver disease. Researchers want to know if glucagon resistance makes liver and heart problems worse. Participants will have scans, blood tests, and fat biopsies to measure how their body processes fat and sugar. The goal is to better understand these conditions, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC ASSOCIATED FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aarhus University Hospital
RECRUITINGAarhus, 8000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.